Fig 1.
Consort Flow Chart.
Table 1.
Baseline characteristics.
Table 2.
Percent of total fatty acids in red blood cell membranes.
Fig 2.
This figure reflects percent of subjects improved by 50% or more from baseline MADRS score. Mixed effects logistic regression model adjusted for age and MS disease duration. No difference between placebo and omega-3 FA was found over 3 months (p = 0.30).
Fig 3.
Linear mixed effects model adjusted for age and MS disease duration, error bars indicate standard error of the mean. No difference between placebo and omega-3 FA was found over 3 months (p = 0.23).
Table 3.
Adverse events.